Walgreens Boots Alliance, Inc. with ticker code (WBA) now have 16 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The target price High/Low ranges between $32.12 and $14.68 suggesting an average analyst share price target price of $20.32. (at the time of writing). Given that the stocks previous close was at $17.93 this is indicating there is a potential upside of 13.3%. Also worth taking note is the 50 day moving average now sits at $18.83 and the 200 day MA is $21.99. The market capitalization for the company is 15.37B. The stock price for the company is currently is currently $17.82 USD
The potential market cap would be $17,422,779,921 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of $167.54 and a 1.12% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
